In clinical practice, although the level of serum prostate-specific antigen (PSA) and multi parameter Magnetic Resonance Imaging (MRI) techniques are widely tested for PCa screening, the sensitivity and specificity are still need to be measured for improving positive detection rate and avoiding unnecessary biopsy. This evidence concerns the gene KLK3 and posterior cortical atrophy.